Evidence map›Paper›PMID 40572757›Full record

ArticleMedicina (Kaunas, Lithuania)2025

FICTION Technique-A Candidate for the Assessment of HER2 Status in Breast Invasive Carcinomas.

Bogdan Fetica, Mihaiela Luminita Blaga, Adrian Pavel Trifa, Cosmina Maria Bocean, Ovidiu Balacescu, Annamaria Fulop, Bogdan Pop

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bogdan FeticaDepartment of Pathology, "Prof. Dr. Ion Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.ORCID 0000-0001-8640-7546
Mihaiela Luminita BlagaMolecular Pathology Laboratory Pathos, 400394 Cluj-Napoca, Romania.ORCID 0000-0002-6873-118X
Adrian Pavel TrifaMedical Genetics Department 2-Morphological Microscopy, Faculty of Medicine "Victor Babeș", University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0002-0229-8643
Cosmina Maria BoceanDepartment of Pathology, "Prof. Dr. Ion Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.
Ovidiu BalacescuDepartment of Functional Genomics, Proteomics and Experimental Pathology, "Prof. Dr. Ion Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.ORCID 0000-0003-0253-7103
Annamaria FulopDepartment of Pathology, "Prof. Dr. Ion Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.
Bogdan PopDepartment of Pathology, "Prof. Dr. Ion Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.ORCID 0000-0001-9092-9611

Funding

Romanian Ministry of Education and Research, CCCDI -UEFISCDI Project number PN-III-P2-2.1-PED-2019-2308, within PNCDI III
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesAdultAgedFemaleHumansImmunohistochemistryIn Situ HybridizationIn Situ Hybridization, FluorescenceMiddle AgedERBB2 protein, humanErb-b2 Receptor Tyrosine Kinasesbreast neoplasmserbB-2fluorescencegenesimmunohistochemistryin situ hybridization

Identifiers

PMID40572757
PMCPMC12195370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.